G&S Capital LLC Eli Lilly & CO Transaction History

G&S Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	BUY	$321.55 - $374.67 $13,505 - $15,736	42 Added 0.78%	5,398 $0
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $1.92 Million - $2.19 Million	-6,478 Reduced 54.74%	5,356 $1.73 Million
Q2 2022 Jul 21, 2022	BUY	$278.73 - $327.27 $44,875 - $52,690	161 Added 1.38%	11,834 $3.84 Million
Q1 2022 Apr 15, 2022	BUY	$234.69 - $291.66 $53,744 - $66,790	229 Added 2.0%	11,673 $3.34 Million
Q4 2021 Jan 20, 2022	SELL	$224.85 - $279.04 $45,644 - $56,645	-203 Reduced 1.74%	11,444 $3.16 Million
Q3 2021 Oct 19, 2021	BUY	$221.6 - $272.71 $2.58 Million - $3.18 Million	11,647 New	11,647 $2.69 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of G&S Capital LLC, based on Form 13F filings with the SEC.

Stay updated on G&S Capital LLC with notifications on news.